Stimulation of murine intestinal secretion by daily genistein injections: Gender-dependent differences

Cellular Physiology and Biochemistry

Volumn 28, Issue 2, 2011, Pages 239-250

  Al Nakkash, Layla ^a   Batia, Lyn ^a   Bhakta, Minoti ^a   Peterson, Amity ^a   Hale, Nathan ^b   Skinner, Ryan ^b   Sears, Steven ^b   Jensen, Jesse ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

CFTR; Genistein; Intestine; Secretion

Indexed keywords

BICARBONATE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHLORIDE ION; GENISTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CHLORIDE TRANSPORT; CONTROLLED STUDY; CRYPT CELL; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; INTESTINE SECRETION; JEJUNUM MUCOSA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEX DIFFERENCE; SHORT CIRCUIT CURRENT; STEADY STATE; TREATMENT DURATION; WEIGHT GAIN;

MURINAE; MUS;

EID: 80052095149     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000331736     Document Type: Article

References (55)

1. Murphy PA: Phytoestrogen content of processed soybean products. Food Technol 1982;36:60-64.
2. Al-Nakkash L, Hu S, Li M, Hwang TC: A common mechanism for cystic fibrosis transmembrane conductance regulator protein activation by genistein and benzimidazolone analogs. J Pharmacol Exp Ther 2001;296:464-472. (Pubitemid 32112474)
3. Moran O, Zegarra-Moran O: A quantitative description of the activation and inhibition of CFTR by potentiators: Genistein. FEBS Letters 2005;579:3979-3983. (Pubitemid 40961899)
4. Schmidt A, Hughes LK, Cai Z, Mendes F, Li H, Sheppard DN, Amaral MD: Prolonged treatment of cells with genistein modulates the expression and function of the cystic fibrosis transmembrane conductance regulator. Br J Pharm 2008;153:1311-1323. (Pubitemid 351415497)
5. Mall M, Wissner A, Seydewitz H, Huber M, Kuehr J, Brandis M, Greger R, Kunzelmann K: Effect of genistein on native epithelial tissue from normal individuals and CF patients and on ion channels expressed in Xenopus oocytes. Br J Pharm 2000;30:1884-1892. (Pubitemid 30655801)
6. Baker MJ, Hamilton KL: Genistein stimulates electrogenic Cl-secretion in the mouse jejunum. Am J Physiol 2004;287:C1636-C1645. (Pubitemid 39507681)
7. Al-Nakkash L, Clarke LL, Rottinghaus GE, Chen YJ, Cooper K, Rubin LJ: Dietary genistein stimulates anion secretion across female murine intestine. J Nutr 2006;136:2785-2790. (Pubitemid 44771774)
8. Chao PC, Hamilton KL: Genistein stimulates electrogenic Cl-secretion via phosphodiesterase modulation in the mouse jejunum. Am J Physiol 2009;297:C688-698.
9. Tuo B, Wen G, Seidler U: Differential activation of the HCO3-conductance through the cystic fibrosis transmembrane conductance regulator anion channel by genistein and forskolin in murine duodenum. Br J Pharm 2009;158:1313-1321.
10. Illek B, Fischer H, Santos GF, Widdicombe JH, Machen TE, Reenstra WW: cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein. Am J Physiol 1995;268:C886-C893.
11. Al-Nakkash L, Hwang TC: Activation of CFTR by pharmacological modulators. Pediatric Pulmonology 1997;14:71-352.
12. Hwang TC, Wang F, Zeltwanger S, Yang I, Reenstra W: Genistein potentiates wildtype and F508-CFTR channel activity. Am J Physiol 1997;273:C988-998. (Pubitemid 27422179)
13. Xu X, Wang H, Murphy P, Cook L, Hendrich S: Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 1994;124:825-832. (Pubitemid 24200587)
14. Noel S, Strale PO, Dannhoffer L, Wilke M, DeJonge H, Rogier C, Mettey Y, Becq F: Stimulation of salivary secretion in vivo by CFTR potentiators in Cftr+/+ and Cftr-/-mice. J Cyst Fibros 2008;7:128-133. (Pubitemid 351372761)
15. Wang F, Zeltwanger S, Yang I, Nairn A, Hwang TC: Actions of genistein on CFTR channel gating. J Gen Physiol 1998;111:477-490.
16. Lim CH, Bijvelds MJ, Nigg A, Schoonederwoerd K, Houtsmuller AB, De Jonge HR, Tilly BC: Cholesterol depletion and genistein as tools to promote F508delCFTR retention as the plasma membrane. Cell Physiol Biochem 2007;20:473-482. (Pubitemid 47340608)
17. Franke AA, Custer LJ, Wang W, Shi CY: HPLC analysis of isoflavonoids and other phenolic agents from human fluids. Proc Soc Exp Biol Med 1998;217:263-273.
18. Bajwa PJ, Lee JW, Straus DS, Lytle C: Activation of PPARg by rosiglitazone attenuates intestinal Cl-secretion. Am J Physiol 2009;297:G82-89.
19. Ameen NA, Martensson B, Bourguinon L, Marino CR, Isenberg J, McLaughlin GE: CFTR channel insertion to the apical surface in rat duodenal villus epithelial ceels is upregulated by VIP in vivo. J Cell Sci 1999;112:887-894. (Pubitemid 29179321)
20. Ameen NA, Marino CR, Salas PJI: cAMP-dependent exocytosis and vesicle traffic regulate CFTR and fluid transport in rat jejunum in vivo. Am J Physiol 2002;284:C429-C438. (Pubitemid 36120081)
21. Golin-Bisello F, Bradbury N, Ameen N: STa and cGMP stimulate CFTR translocationto the surface of villus enterocytes in rat jejunum and is regulated by protein kinsae G. Am J Physiol 2005;289:C708-C716. (Pubitemid 41192680)
22. Clarke LL, Harline MC: Dual role of CFTR in cAMP-stimulated HCO3-secretion across murine duodenum. Am J Physiol 1998;274:G718-G726.
23. Goddard CA, Evans M, Colledge W: Genistein activates CFTR-mediated Clsecretion in the murine trachea and colon. Am J Physiol 2000;279:C383-C392.
24. Grubb BR: Ion transport across the jejunum in normal and cystic fibrosis mice. Am J Physiol 1995;268: G505-G513.
25. Clarke LL, Grubb BR, Gabriel SE, Smithies O, Coller BH, Boucher RC: Defective epithelial chloride transport in a genetargeted mouse model of cystic fibrosis. Science 1992;257:1125-1128.
26. Clarke LL, Harline MC: CFTR is required for cAMP inhibition of intestinal Na+ absorption in a cystic fibrosis mouse model. Am J Physiol 1996;270:G259-G267.
27. Sheldon RJ, Malarchik ME, Fox DA, Burks TF, Porreca F: Pharmacological characterization of neural mechanisms regulating mucosal ion transport in mouse jejunum. J Pharmacol Exp Ther 1988;249:572-582. (Pubitemid 19144851)
28. Robert R, Norez C, Becq F: Disruption of CFTR chloride channel alters mchanical properties and cAMPdependent Cl-transport of mouse aortic smooth muscle cells. J Physiol 2005;568:483-495. (Pubitemid 41555453)
29. Noel S, Faveau C, Norez C, Rogier C, Mettey Y, Becq F: Discovery of pyrrolo[2,3-b]pyrazines derivatives as submicromolar affinity activators of wild type, G551D, and F508del cystic transmembrane conductance regulator chloride channels. J Pharmacol Exp Ther 2006;319:349-359. (Pubitemid 44455142)
30. Hamilton KL, Kiessling M: DCEBIO stimulates Cl-secretion in the mouse jejunum. Am J Physiol 2006;290:C152-C164.
31. Wu D, Hu Z: Rutaecarpine induces chloride secretion across rat isolated distal colon. J Pharmacol Exp Ther 2008;325:256-266. (Pubitemid 351439168)
32. Chen M, Du J, Jiang W, Zuo W, Wang F, Li M, Wu Z, Chan H, Zhou W: Functional expression of cystic fibrosis transmebrane conductance regulator in rat oviduct epithelium. Acta Biochim Biophys Sin 2008;40:864-872.
33. Lamhonwah AM, Bear CE, Huan LJ, Chiaw PK, Ackerly CA, Tein I: Cystic fibrosis transmembrane conductance regulator in human muscle dysfunction causes abnormal metabolic recovery in exercise. Ann Neurol 2010;67:802-808.
34. Doerge DR, Twaddle NC, Banks EP, Jefferson WN, Newbold RR: Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice. Cancer Lett 2002;184:21-27. (Pubitemid 34718103)
35. Anderson MP, Welsh MJ: Calcium and cAMP activate different chloride channels in the apical membrane of normal and cystic fibrosis epithelia. Proc Natl Acad Sci USA 1991;88:6003-6007. (Pubitemid 21914874)
36. Clarke LL, Grubb BR, Yankaskas JR, Cotton CU, McKenzie A, Boucher RC: Relationship of a non-cystic fibrosis transmembrane conductance regulatormediated chloride conductance to organlevel disease in Cftr(-/-) mice. Proc Natl Acad Sci USA 1994;91:479-483.
37. Grubb BR: Ion transport across the normal and CF neonatal murine intestine. Am J Physiol 1999;277:G167-G174. (Pubitemid 29352658)
38. Al-Nakkash L, Reinach PS: Activation of a CFTR-mediated chloride current in a rabbit corneal epithelial cell line. Invest Ophthalmol Vis Sci 2001;42:2364-2370. (Pubitemid 32848867)
39. Krueger D, Gruber L, Buhner S, Zeller F, Langer R, Seidl S, Michel K, Scheimann M: The multi-herbal drug STW 5 (Iberogast) has presecretory action in the human intestine. Neurogastroenterol Motil 2009;21:1203-e1110.
40. Hoque KM, Woodward OM, van Rossum D, Zachos NC, Chen L, Leung GPH, Guggino WB, Guggino SB, Tse CM: Epac1 mediates protein kinase A-independent mechanisms of forskolin-activated intestinal chloride secretion. J Gen Physiol 2010;135:43-58.
41. Cermak R, Kuhn G, Wolffram S: The favonol quercetin activates basolateral K+ channels in rat distal colon epithelium. Br J Pharm 2002;135:1183-1190. (Pubitemid 34259119)
42. Gyomorey K, Garami E, Galley K, Rommens JM, Bear CE: Non-CFTR chloride channels likely contribute to secretion in the murine small intestine. Pflugers Arch 2001;443:S103-S106. (Pubitemid 33086962)
43. Mohammed-Panah R, Ackerly CA, Rommens JM, Choudhury M, Wang Y, Bear CE: The chloride channel ClC-4 colocalizes with cystic fibrosis transmebrane conductance regulator and may mediate chloride flux across the apical membrane of intestinal epithelia. J Biol Chem 2002;277:566-574. (Pubitemid 34952093)
44. Leverkoehne I, Holle H, Anton F, Gruber AD: Difefrential expression of calciumactivated chloride channels (CLCA) gene family members in the small intestine of cystic fibrosis mouse models. Histochem Cell Biol 2006;126:239-250.
45. Devor DC, Singh AK, Gerlach AC, Frizzell RA, Bridges RJ: Inhibition of intestinal Cl-secretion by clotrimazole: direct effect on basolateral membrane K+ channels. Am J Physiol 1997;273:C531-C540.
46. Hamilton KL, Meads L, Butt AG: 1-EBIO stimulates Cl-scretion by activating a basolateral K+ channel in the mouse jejunum. Pflugers Arch 1999;439:158-166. (Pubitemid 30055520)
47. Heaps C, Bowles D: Gender-specific K+-channel contribution to adenosineinduced relaxation in coronary arterioles. J Appl Physiol 2002;92:550-558. (Pubitemid 34671019)
48. Lehrich RW, Aller SG, Webster P, Marino CR, Forrest JN: Vasoactive intestinal peptide, forskolin and genistein increase apical CFTR trafficking in the rectal gland of the Spiny Dogfish, Sqalus acanthias. J Clin Invest 1998;101:737-745. (Pubitemid 28096069)
49. Michopoulou A, Triggas B, Hra E, Spyratou C, Milonas A, Perrea D, Donta I, Papadopoulos S: Early intestinal morphological changes following benazlkolinium chloride treatment in a rat model of short bowel syndrome. Ann Ital Chir 2009;80:135-139.
50. Pedemonte N, Lukacs GL, Du K, Caci E, Zegarra-Moran O, Galietta LJV, Verkman AS: Small-molecule correctors of defective deltaF508 cellular processing identified by high throughput screening. J Clin Invest 2005;115:2564-2571. (Pubitemid 41266219)
51. Caputo A, Hinzpeter A, Caci E, Pedemonte N, Arous N, Di Duca M, Zegarra-Moran O, Fanen P, Galietta LJV: Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators. J Pharmacol Exp Ther 2009;330:783-791.
52. Van Goor F, Hadida S, Grootenhuis PD, Burton B, Cao D, Neuberger T, Turnbull A, Singh A, Joubran J, Hazlewood A, Zhou J, McCartney J, Arumugam V, Decker C, Yang J, Young C, Olson ER, Wine JJ, Frizzell RA, Ashlock M, Negulescu P: Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. PNAS USA 2009;106:18825-18830.
53. Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW, Donaldson SH, Moss RB, Pilewski JM, Rubenstein RC, Uluer AZ, Aitken ML, Freedman SD, Rose LM, Mayer-Hamblett N, Dong Q, Zha J, Stone AJ, Olson ER, Ordoñez CL, Campbell PW, Ashlock MA, Ramsey BW: Effect of VX-770 in presons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010;363:1991-2003.
54. Marini H, Minutoli L, Polito F, Bitto A, Altavilla D, Atteritano M, Gaudio A, Mazzaferro S, Frisina A, Frisina N, Lubrano C, Bonaiuto M, D'Anna R, Cannata ML, Corrado F, Adamo EB, Wilson S, Squadrito F: Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women. Ann Intern Med 2007;146:839-847. (Pubitemid 351650484)
55. Abebe W, Agrawal DK: Role of tyrosine kinases in norephinephrine contraction of vascular smooth muscle. J Cardiovasc Pharmacol 1995;26:153-159.